What NVIDIA's Q2 FY27 report means for your Indian portfolio

NVIDIA reports fiscal Q2 FY27 results between August 20-22. The quarter matters. But if you hold NVDA as an Indian resident investor, the quarter is actually the least important thing you need to read correctly. What matters is the guidance, the gross margin line, and — critically for your tax situation — what you do with your position in response.

Here is how to read the print clearly.

The bar is already set very high

Q1 FY27 data center revenue came in at $75.2 billion, up 92% year-on-year. That is the baseline the market is comparing against. Analyst consensus for Q2 is in the $76–82 billion range, which implies continued sequential growth on top of an already extraordinary number.

The market is not asking whether NVIDIA is a good business. It is priced for one. The question the earnings report answers is narrower: did the quarter and the forward guide beat an expectation that is already embedded in the stock price? That is a meaningfully harder bar to clear.

The 4 things that actually move the stock

Retail investors watch EPS and revenue. The market watches four other things.

Data center revenue versus consensus. With Q2 consensus at $76–82 billion, the print itself needs to be at the upper end or above that range to drive a positive reaction. A number at the low end of consensus — even if it is technically a year-on-year growth record — may read as a miss.

Blackwell GPU gross margin recovery. Blackwell architecture had gross margin headwinds at launch — new chip generations always do. The market expects Q2 to show recovery toward the 70%+ gross margin target. If Blackwell margins are still compressing at 65-68%, that signals supply-chain cost pressure the stock is not fully pricing in.

Q3 FY27 forward guidance. This is more important than the Q2 number. When NVIDIA says "we guide Q3 revenue to $X billion," analysts compare that to what they were modeling for Q3. If guidance is in-line or below, the stock can drop even on a strong Q2 beat. This happens more often than first-time earnings watchers expect — a company reports a great quarter, the stock falls 8%, and retail investors are confused. Guidance miss is usually why.

H20 China revenue disclosure. US export controls banned H20 chip sales to China in April 2026. Q2 FY27 is the first full quarter without that revenue stream. The market has partially priced this — analyst estimates for H20 revenue loss are roughly $8–10 billion annualized — but management's explicit disclosure of the impact and the offset from sovereign AI demand (India, Saudi Arabia, UAE) is the key data point. If the sovereign offset has materialized at scale, it neutralizes the China loss. If it has not, the gap is real.

What "guidance" actually means — plainly

US companies guide forward one quarter. When NVIDIA says it expects Q3 revenue of $80 billion, that is management's own estimate for next quarter, not an analyst number. Analysts have their own consensus — say, $82 billion. If management guides $80 billion against a consensus of $82 billion, that is a guidance miss of $2 billion. The stock reacts to the gap between management's guide and analyst expectations, not to whether the guide is a large number in absolute terms.

The trap: a retail investor sees NVIDIA guiding $80 billion in quarterly revenue and thinks "that is amazing, I should buy more." A professional investor sees the same guide and notes it came in $2 billion below consensus, and sells. Both are responding rationally to different reference points.

This is the single most important concept to internalize before reading any US earnings report. The number itself is secondary. The gap to expectation is primary.

The Indian investor's specific calculus

This is the section that actually applies to your situation, not just the quarter.

If you bought NVDA less than 24 months ago, any gain you crystallize — whether before, during, or after the earnings event — is taxed as short-term capital gain under Section 112. That means your marginal income tax rate. For most readers of this publication, that is 30% plus surcharge. A sharp post-earnings rally sounds appealing; running the STCG math on it usually is not.

If you have held more than 24 months, your gain qualifies as long-term at 12.5%, no indexation. That is a materially different outcome. Do not accidentally reset your LTCG clock by trading around a short-term event.

The Schedule FA requirement does not depend on whether you sell. NVDA is a foreign asset. You disclose it in Schedule FA of your ITR every calendar year you hold it — even if you bought and sold within the year, even at a loss. The disclosure basis is calendar year, not the Indian financial year. Non-disclosure is not a technicality; it carries Black Money Act penalties. Use the Schedule FA helper to generate the right numbers.

Position sizing before an event is a cleaner decision than trading through it. If NVDA is more than 10–15% of your US allocation, the earnings print creates real concentration risk — a single report can move the stock 10% in either direction in after-hours trading. The better structural decision is to right-size the position before the event at a known tax rate, rather than hoping for a post-earnings outcome that may not arrive.

What to actually do — three scenarios

You have a long-term thesis on AI infrastructure. A single quarter does not change a multi-year thesis. Hold through the print. The relevant question is whether hyperscaler AI capex remains on track — and by the time NVDA reports on August 20-22, Microsoft, Google, Meta, and Amazon will have already reported and given their FY27 capex direction. That context will tell you more about NVDA's forward demand than NVDA's own Q2 number will.

You bought NVDA recently, it is under 24 months, and it is a large position. Consider right-sizing now at STCG rather than waiting for a post-earnings pop that may not come. If a post-earnings pop does come and you sell into it, you still pay STCG — but you also took the event risk. The math for reducing ahead of the print is often better than it looks when you model it correctly. Run your numbers with the US capital-gains calculator.

You do not currently hold NVDA. If you want NVIDIA exposure, buying before a binary event is the highest-risk entry point. A post-earnings pullback — if guidance disappoints — is historically a better entry for a long-term position. You also already have NVDA exposure if you hold VTI, QQQ, or any India-facing Nasdaq fund of funds — NVDA is a top-3 weight in QQQ and a major weight in VOO and VTI. That diversified exposure has no single-stock event risk.

One thing to keep in mind

This is not a call to buy or sell. It is a framework for reading what the NVIDIA Q2 FY27 report actually means — what numbers to watch, why guidance matters more than actuals, and how to think about your position in a tax-efficient way as an Indian resident. The quarter will tell you something. What you do with it should depend on your holding period, your position size, and your thesis — not on how the stock moves in the first 30 minutes of after-hours trading.

---

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Cross-references

• How to buy NVIDIA from India — the mechanics, full tax math, and the $60k estate-tax trap
• Q2 2026 earnings preview — the five narratives driving this entire earnings season
• How US stocks are taxed in India — foundational Section 112 treatment
• LRS explained for Indian investors — remittance mechanics and TCS
• Direct stocks vs US ETFs — when NVDA directly makes sense vs QQQ exposure

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.